Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combinatorial Gene Control02:33

Combinatorial Gene Control

Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of JL1037 as a novel, specific, reversible lysine-specific demethylase 1 inhibitor that induce apoptosis and autophagy of AML cells.

Oncotarget·2017
Same author

Probing antibody internal dynamics with fluorescence anisotropy and molecular dynamics simulations.

mAbs·2013
Same author

Pfizer Global Virtual Library (PGVL): a chemistry design tool powered by experimentally validated parallel synthesis information.

ACS combinatorial science·2012
Same author

Novel inhibitors of Mycobacterium tuberculosis dTDP-6-deoxy-L-lyxo-4-hexulose reductase (RmlD) identified by virtual screening.

Bioorganic & medicinal chemistry letters·2011
Same author

Optimization of potent, selective, and orally bioavailable pyrrolodinopyrimidine-containing inhibitors of heat shock protein 90. Identification of development candidate 2-amino-4-{4-chloro-2-[2-(4-fluoro-1H-pyrazol-1-yl)ethoxy]-6-methylphenyl}-N-(2,2-difluoropropyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxamide.

Journal of medicinal chemistry·2011
Same author

Chemoinformatics and library design.

Methods in molecular biology (Clifton, N.J.)·2010

Related Experiment Video

Updated: Jul 6, 2026

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids
08:21

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids

Published on: April 13, 2022

Structure-directed combinatorial library design.

Joe Zhongxiang Zhou1

  • 1Department of Structural and Computational Biology, Pfizer Global Research & Development, La Jolla Laboratories, San Diego, CA 92121, USA. joe.zhou@pfizer.com

Current Opinion in Chemical Biology
|March 11, 2008
PubMed
Summary
This summary is machine-generated.

Pharmaceutical companies accelerate drug discovery using structure-based, combinatorial library, and fragment-based drug design. This review explores their integration and computational advancements for efficient lead optimization.

More Related Videos

High-Density DNA and RNA microarrays - Photolithographic Synthesis, Hybridization and Preparation of Large Nucleic Acid Libraries
11:22

High-Density DNA and RNA microarrays - Photolithographic Synthesis, Hybridization and Preparation of Large Nucleic Acid Libraries

Published on: August 12, 2019

Automated Robotic Liquid Handling Assembly of Modular DNA Devices
11:22

Automated Robotic Liquid Handling Assembly of Modular DNA Devices

Published on: December 1, 2017

Related Experiment Videos

Last Updated: Jul 6, 2026

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids
08:21

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids

Published on: April 13, 2022

High-Density DNA and RNA microarrays - Photolithographic Synthesis, Hybridization and Preparation of Large Nucleic Acid Libraries
11:22

High-Density DNA and RNA microarrays - Photolithographic Synthesis, Hybridization and Preparation of Large Nucleic Acid Libraries

Published on: August 12, 2019

Automated Robotic Liquid Handling Assembly of Modular DNA Devices
11:22

Automated Robotic Liquid Handling Assembly of Modular DNA Devices

Published on: December 1, 2017

Area of Science:

  • Drug discovery and development
  • Computational chemistry
  • Medicinal chemistry

Background:

  • Pharmaceutical companies increasingly use computational methods to accelerate drug discovery.
  • Structure-based drug design (SBDD) and combinatorial library design (CLD) are established techniques.
  • Fragment-based drug design (FBDD) is emerging as a significant tool.

Purpose of the Study:

  • To review the integration of SBDD, CLD, and FBDD in drug discovery.
  • To highlight advancements in computational methodologies for synergistic application of these techniques.
  • To provide insights into future directions in drug design.

Main Methods:

  • Review of current literature on drug design methodologies.
  • Analysis of computational tools and techniques.
  • Case studies of integrated drug design approaches.

Main Results:

  • The synergy between SBDD, CLD, and FBDD enhances lead discovery and optimization.
  • Computational advancements facilitate the integration of these design strategies.
  • Successful examples demonstrate the power of combining these techniques.

Conclusions:

  • Integrated drug design approaches, powered by computational methods, are crucial for efficient pharmaceutical research.
  • The combination of SBDD, CLD, and FBDD offers a robust strategy for modern drug development.
  • Future research should focus on further refining computational tools for seamless integration.